Literature DB >> 21769133

Essential role of DOT1L in maintaining normal adult hematopoiesis.

Anh T Nguyen, Jin He, Olena Taranova, Yi Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21769133      PMCID： PMC3166961          DOI： 10.1038/cr.2011.115

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

Review 1.  The diverse functions of histone lysine methylation.

Authors:  Cyrus Martin; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

2.  DOT1L regulates dystrophin expression and is critical for cardiac function.

Authors:  Anh T Nguyen; Bin Xiao; Ronald L Neppl; Eric M Kallin; Juan Li; Taiping Chen; Da-Zhi Wang; Xiao Xiao; Yi Zhang
Journal:  Genes Dev       Date:  2011-02-01       Impact factor: 11.361

3.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

Review 4.  The diverse functions of Dot1 and H3K79 methylation.

Authors:  Anh Tram Nguyen; Yi Zhang
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

5.  hDOT1L links histone methylation to leukemogenesis.

Authors:  Yuki Okada; Qin Feng; Yihui Lin; Qi Jiang; Yaqiang Li; Vernon M Coffield; Lishan Su; Guoliang Xu; Yi Zhang
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

6.  Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.

Authors:  Stephanie Y Jo; Eric M Granowicz; Ivan Maillard; Dafydd Thomas; Jay L Hess
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

7.  Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain.

Authors:  Qin Feng; Hengbin Wang; Huck Hui Ng; Hediye Erdjument-Bromage; Paul Tempst; Kevin Struhl; Yi Zhang
Journal:  Curr Biol       Date:  2002-06-25       Impact factor: 10.834

8.  H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

Authors:  Andrei V Krivtsov; Zhaohui Feng; Madeleine E Lemieux; Joerg Faber; Sridhar Vempati; Amit U Sinha; Xiaobo Xia; Jonathan Jesneck; Adrian P Bracken; Lewis B Silverman; Jeffery L Kutok; Andrew L Kung; Scott A Armstrong
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

9.  Early mammalian erythropoiesis requires the Dot1L methyltransferase.

Authors:  Yi Feng; Yanping Yang; Manoela M Ortega; Jessica N Copeland; Mingcai Zhang; Jennifer B Jacob; Timothy A Fields; Jay L Vivian; Patrick E Fields
Journal:  Blood       Date:  2010-08-26       Impact factor: 22.113

10.  The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure.

Authors:  Brendan Jones; Hui Su; Audesh Bhat; Hong Lei; Jeffrey Bajko; Sarah Hevi; Gretchen A Baltus; Shilpa Kadam; Huili Zhai; Reginald Valdez; Susana Gonzalo; Yi Zhang; En Li; Taiping Chen
Journal:  PLoS Genet       Date:  2008-09-12       Impact factor: 5.917
  10 in total
  34 in total

Review 1.  The emerging roles of DOT1L in leukemia and normal development.

Authors:  C M McLean; I D Karemaker; F van Leeuwen
Journal:  Leukemia       Date:  2014-05-23       Impact factor: 11.528

Review 2.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

3.  MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.

Authors:  Simone S Riedel; Jessica N Haladyna; Matthew Bezzant; Brett Stevens; Daniel A Pollyea; Amit U Sinha; Scott A Armstrong; Qi Wei; Roy M Pollock; Scott R Daigle; Craig T Jordan; Patricia Ernst; Tobias Neff; Kathrin M Bernt
Journal:  J Clin Invest       Date:  2016-02-29       Impact factor: 14.808

Review 4.  The molecular mechanics of mixed lineage leukemia.

Authors:  R K Slany
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

Review 5.  Disordered epigenetic regulation in MLL-related leukemia.

Authors:  Yue Zhang; Aili Chen; Xiao-Mei Yan; Gang Huang
Journal:  Int J Hematol       Date:  2012-09-29       Impact factor: 2.490

6.  MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.

Authors:  Nan Zhu; Mo Chen; Rowena Eng; Joshua DeJong; Amit U Sinha; Noushin F Rahnamay; Richard Koche; Fatima Al-Shahrour; Janna C Minehart; Chun-Wei Chen; Aniruddha J Deshpande; Haiming Xu; S Haihua Chu; Benjamin L Ebert; Robert G Roeder; Scott A Armstrong
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

Review 7.  Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.

Authors:  Chun-Wei Chen; Scott A Armstrong
Journal:  Exp Hematol       Date:  2015-06-25       Impact factor: 3.084

8.  DOT1L-mediated H3K79 methylation in chromatin is dispensable for Wnt pathway-specific and other intestinal epithelial functions.

Authors:  Li-Lun Ho; Amit Sinha; Michael Verzi; Kathrin M Bernt; Scott A Armstrong; Ramesh A Shivdasani
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

Review 9.  The role of chromatin modifiers in normal and malignant hematopoiesis.

Authors:  Jill S Butler; Sharon Y R Dent
Journal:  Blood       Date:  2013-01-02       Impact factor: 22.113

Review 10.  A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L.

Authors:  Justin L Anglin; Yongcheng Song
Journal:  J Med Chem       Date:  2013-08-14       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.